Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
Pradip Pawar/LinkedIn
Jun 26, 2026, 18:27

Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century

Pradip Pawar, Senior Executive at Intas Pharmaceuticals, Analyst Grade J5 at Serum Institute of India Pvt. Ltd., shared a post on LinkedIn:

“Cell and Gene Therapy: Transforming Medicine in the 21st Century:

Over the past decade, cell and gene therapy has evolved from a visionary concept into a rapidly maturing field that is reshaping the very foundations of modern medicine. What was once considered experimental science is now delivering approved therapies, saving lives, and offering hope to patients with conditions previously deemed untreatable.

This transformation is not only scientific but deeply human. It represents a paradigm shift: from managing symptoms to pursuing cures, from generalized treatments to personalized interventions, and from incremental progress to disruptive innovation.

The Current Scope of Cell and Gene Therapy

The scope of cell and gene therapy today is vast and expanding:

  • Oncology breakthroughs: CAR-T cell therapies have revolutionized treatment for hematological malignancies, achieving remission in patients who had exhausted conventional options. Research is now extending into solid tumors, a frontier that could redefine cancer care.
  • Rare disease interventions: Gene therapies targeting single-gene disorders such as spinal muscular atrophy, hemophilia A (Factor VIII deficiency), and hemophilia B (Factor IX deficiency) are demonstrating curative potential.
  • Regenerative medicine: Stem cell therapies are being applied to restore damaged tissues in cardiovascular disease, neurodegeneration, and orthopedic injuries.
  • Neurological applications: Advances in gene editing and delivery systems are opening possibilities for conditions like Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis.
  • The pipeline is robust: thousands of therapies are in clinical development worldwide, with dozens already approved. This breadth reflects the versatility of the science and its ability to address diverse medical challenges

Scientific Importance

The scientific importance of cell and gene therapy lies in its ability to address the root cause of disease. Unlike conventional treatments that often manage symptoms, these therapies aim to correct or replace defective genes, reprogram immune cells, or regenerate damaged tissues.

  • Gene replacement: Delivering functional copies of genes to patients with inherited disorders.
  • Gene editing: Technologies like CRISPR-Cas9 allow precise correction of mutations, offering permanent solutions.
  • Cell reprogramming: Engineering immune cells (like CAR-T) to recognize and destroy cancer cells.
  • Regeneration: Using stem cells to repair or replace damaged tissues, restoring function rather than compensating for loss.

These approaches embody the future of medicine: targeted, durable, and potentially curative.”

Stay updated with Hemostasis Today.

amyotrophic lateral sclerosis bleeding disorders Blood CAR-T cell therapies Cardiovascular Disease Cell and Gene Therapy CRISPR-Cas9 Factor IX Factor IX deficiency Factor VIII deficiency Gene therapy Health Hematology Hemophilia Hemophilia A Hemophilia B Hemostasis Hemostasis News Hemostasis Today Huntington’s Disease Medicine neurodegeneration Parkinson's disease Pradip Pawar Stem Cell Therapy
NewsFeed